Overview of genetic and epigenetic alterationsin the pathogenesis of esophagogastric junctional adenocarcinoma and esophageal adenocarcinoma: recent findings by next generation sequencing

Abstract

Esophagogastric junctional adenocarcinoma is commonly treated as esophageal adenocarcinoma (EAC), and has dramatically increased in Western countries for several decades. The similar trend has been observed in Asian countries (not in China). Barrett's esophagus (BE) is a widely accepted precursor of EAC. Recent advances of next-generation sequencing could provide researchers with a better understanding of genetic and epigenetic alterations in the carcinogenesis of EAC. In this review, we have summarized the recently reported major genetic and epigenetic alterations in both BE and EAC. Sonic hedgehog/bone morphogenetic protein axis, which is a key signaling for esophageal development, plays an important role in BE intestinal metaplasia. Single nucleotide polymorphisms related to esophageal organogenesis, such as FOXF1 and FOXP3, are frequently detected in BE patients. During progression of BE to adenocarcinoma, lacking of normal function of TP53 and CDKN2A by loss of heterozygosity (LOH), mutation, or promoter methylation has been frequently observed. LOH at 9p (coding CDKN2A) is an earlier event to EAC carcinogenesis compared to that at 17q (coding TP53) LOH. In order to further elucidate the pathogenesis of BE and EAC, it will be necessary to analyze these genetic/epigenetic alterations in combination with clinical data in a large-scale cohort.

Keywords

Barrett’s esophagus / carcinogenesis / epigenetic / esophageal adenocarcinoma / esophagogastric junctional adenocarcinoma / genetic / intestinal metaplasia

References

[1] Rudiger Siewert J,Werner M.Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients..Ann Surg2000;232:353-61 PMCID:PMC1421149

[2] Sobin L,Wittekind C.International Union against Cancer. TNM classification of malignant tumours, 7th edn.2010;Chichester, NJWiley

[3] Hur C,Kong CY,Nattinger KJ,Feuer EJ.Trends in esophageal adenocarcinoma incidence and mortality..Cancer2013;119:1149-58 PMCID:PMC3744155

[4] Kusano C,Khor CJ,Kato H,Shimoda T.Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan..J Gastroenterol Hepatol2008;23:1662-5

[5] Rubenstein JH.Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma..Gastroenterology2015;149:302-17.e1

[6] Spechler SJ.Barrett esophagus and risk of esophageal cancer: a clinical review..JAMA2013;310:627-36

[7] Chandra S,Leggett CL.Barrett's esophagus in 2012: updates in pathogenesis, treatment, and surveillance..Curr Gastroenterol Rep2013;15:322 PMCID:PMC3815689

[8] Ek WE,D'Amato M,Magnusson PK,Onstad LE,Tornblom H,Romero Y,Barrett's Esophagus Registry C,Murray LJ,Liu G,Casson AG,Shaheen NJ,Reid BJ,Hardie LJ,Wu AH,Spector TD,Vaughan TL,MacGregor S.Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux..J Natl Cancer Inst2013;105:1711-8 PMCID:PMC3833931

[9] Flejou JF.Barrett's oesophagus: from metaplasia to dysplasia and cancer..Gut2005;54 Suppl 1:i6-12

[10] American Gastroenterological A,Sharma P,Inadomi JM.American Gastroenterological Association medical position statement on the management of Barrett's esophagus..Gastroenterology2011;140:1084-91

[11] Spechler SJ.Barrett's esophagus..N Engl J Med1986;315:362-71

[12] Paull A,Dalton MD,Loeb P.The histologic spectrum of Barrett's esophagus..N Engl J Med1976;295:476-80

[13] Thompson JJ,Enterline HT.Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction..Hum Pathol1983;14:42-61

[14] Chang CL,Save V,Laskey R.Retinoic acid-induced glandular differentiation of the oesophagus..Gut2007;56:906-17 PMCID:PMC1994378

[15] Bellin C,Wiernsperger NF.Generation of reactive oxygen species by endothelial and smooth muscle cells: influence of hyperglycemia and metformin..Horm Metab Res2006;38:732-9

[16] Marchetti M,Pringault E.Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes..J Cell Sci2003;116:1429-36

[17] Kong J,Isariyawongse BK,Silberg DG,Lynch JP.Induction of intestinalization in human esophageal keratinocytes is a multistep process..Carcinogenesis2009;30:122-30 PMCID:PMC2722140

[18] Kalabis J,Vega ME,Robertson ES,Nakagawa H.Isolation and characterization of mouse and human esophageal epithelial cells in 3D organotypic culture..Nat Protoc2012;7:235-46 PMCID:PMC3505594

[19] Boch JA,Antonioli DA,Sawhney RA.Distribution of cytokeratin markers in Barrett's specialized columnar epithelium..Gastroenterology1997;112:760-5

[20] Daniely Y,Dixon D,Lori A,Oren M.Critical role of p63 in the development of a normal esophageal and tracheobronchial epithelium..Am J Physiol Cell Physiol2004;287:C171-81

[21] Wang X,Yamamoto Y,Wei TS,Vincent M,Bellizzi AM,Crum CP,McKeon F.Residual embryonic cells as precursors of a Barrett's-like metaplasia..Cell2011;145:1023-35 PMCID:PMC3125107

[22] Que J,Schwartz RJ.Multiple roles for Sox2 in the developing and adult mouse trachea..Development2009;136:1899-907 PMCID:PMC2680112

[23] Jacobs IJ,Que J.Genetic and cellular mechanisms regulating anterior foregut and esophageal development..Dev Biol2012;369:54-64 PMCID:PMC3409292

[24] Ishizuya-Oka A.Sonic hedgehog and bone morphogenetic protein-4 signaling pathway involved in epithelial cell renewal along the radial axis of the intestine..Digestion2008;77 Suppl 1:42-7

[25] Mari L,Parikh K,Everts V,Fockens P,Krishnadath KK.A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia..Cell Rep2014;7:1197-210

[26] Wang DH,Miyashita T,Zhang W,Corcoran-Schwartz IM,Montgomery EA,Jenkins NA,Harmon JW,Watkins DN.Aberrant epithelial-mesenchymal Hedgehog signaling characterizes Barrett's metaplasia..Gastroenterology2010;138:1810-22 PMCID:PMC3422577

[27] Zhang X,Hart J.Expression of SOX9 and CDX2 in nongoblet columnar-lined esophagus predicts the detection of Barrett's esophagus during follow-up..Mod Pathol2015;28:654-61

[28] Van Dop WA,Uhmann A,Offerhaus GJ,Kasper M,Hardwick JC,Hommes DW,Hahn H.Hedgehog signalling stimulates precursor cell accumulation and impairs epithelial maturation in the murine oesophagus..Gut2013;62:348-57

[29] Clemons NJ,Croagh D,Fennell CM,Scott AM,Phillips WA.Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus..Am J Physiol Gastrointest Liver Physiol2012;303:G1335-46

[30] Quante M,Abrams JA,Good P,Lee Y,Asfaha S,Mahmood U,Kitajewski J,Lightdale CJ,Wang TC.Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasia..Cancer Cell2012;21:36-51 PMCID:PMC3266546

[31] Palles C,Li X,Farnham G,Peppelenbosch MP,Adams CL,Briggs S,Sanders S,Haigh C,Love S,deCaestecker J,Rathbone B,Barr H,Watson P,Maroo N,Underwood T,McMurtry H,Patel P,Al Dulaimi D,Koss K,Trudgill N,Rembacken B,Green E,Kuipers EJ,Paterson S,Beales I,Mullins P,Farrant M,Kelly S,Wajed S,Sawyer E,Onstad L,Corley DA,Bird NC,Reid BJ,Liu G,Bernstein L,Casson AG,Whiteman DC,Levine DM,Verhaar AP,Toxopeus EL,Wijnhoven BP,Krishnadath K,Trynka G,Reynolds JV,MacMathuna P,Kelleher D,Cleynen I,Tomlinson I.Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus..Gastroenterology2015;148:367-78 PMCID:PMC4315134

[32] Su Z,Strange A,Band G,Lescai F,Nanji M,van der Winkel A,Sasieni P,Howarth K,Trudgill N,Pirinen M,van der Laan LJ,Drenth JP,Reynolds JV,McManus R,Prenen H,Krishnadath K,van Baal JW,Petty R,Burch N,Paterson S,Penman I,Ang Y,Patel P,Mullins P,Bird NC,Shaheen NJ,Koss K,Romero Y,Zhang R,Corley DA,Risch HA,Sargeant I,Smart H,McMurtry H,Liu G,Chow WH,Tawil A,Nwokolo C,Rodgers C,MacDonald C,Monk D,Wajed S,Gibbons M,Church N,Griffin M,Deloukas P,Gray E,Potter SC,Anderson M,Blackwell JM,Brown MA,Corvin A,Markus HS,Palmer CN,Rautanen A,Trembath RC,Wood N,Wijmenga C,Atherfold P,Gellatly NL,Cooper SC,Lind T,Ferry D,Brown J,Attwood S,Watson P,Ek W,Moayyedi P,Barr H,Vaughan TL,Spencer CC,Donnelly P,Esophageal Adenocarcinoma Genetics C.Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus..Nat Genet2012;44:1131-6 PMCID:PMC3459818

[33] Martin V.Review of genetic factors in intestinal malrotation..Pediatr Surg Int2010;26:769-81 PMCID:PMC2908440

[34] Levine DM,Zhang R,Onstad L,Lao-Sirieix P,Corley DA,Bird NC,Murray LJ,Chow WH,Nyren O,Liu G,Bernstein L,Casson AG,Harrington P,Debiram-Beecham I,Hayward NK,Fitzgerald RC,Whiteman DC.A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus..Nat Genet2013;45:1487-93 PMCID:PMC3840115

[35] Gu Y,Li JL,Chen Z,Tian L,Shen H,Hochwald SN,Wu L.Altered LKB1/CREB-regulated transcription co-activator (CRTC) signaling axis promotes esophageal cancer cell migration and invasion..Oncogene2012;31:469-79

[36] Woo J,Kim BM,Shivdasani RA.Barx1-mediated inhibition of Wnt signaling in the mouse thoracic foregut controls tracheo-esophageal septation and epithelial differentiation..PLoS One2011;6:e22493

[37] Miletich I,Sharpe PT.Barx1 and evolutionary changes in feeding..J Anat2005;207:619-22 PMCID:PMC1571555

[38] Logan CY.The Wnt signaling pathway in development and disease..Annu Rev Cell Dev Biol2004;20:781-810

[39] Yamamoto S,Matsuura M,Matsumura K,Yamaguchi Y,Chiba T.Heparan sulfate on intestinal epithelial cells plays a critical role in intestinal crypt homeostasis via Wnt/beta-catenin signaling..Am J Physiol Gastrointest Liver Physiol2013;305:G241-9

[40] Niehrs C.The complex world of WNT receptor signalling..Nat Rev Mol Cell Biol2012;13:767-79

[41] Blache P,Duluc I,Berta P,Clevers H.SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes..J Cell Biol2004;166:37-47 PMCID:PMC2172132

[42] Ogaki S,Kume K.Wnt and Notch signals guide embryonic stem cell differentiation into the intestinal lineages..Stem Cells2013;31:1086-96

[43] Fortini ME.Notch signaling: the core pathway and its posttranslational regulation..Dev Cell2009;16:633-47

[44] Galipeau PC,Blount PL,Sanchez CA,Ayub K,Vaughan TL.NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma..PLoS Med2007;4:e67

[45] Barrett MT,Sanchez CA,Reid BJ.Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms..Oncogene1996;12:1873-8

[46] Dunn J,Dolan K,Sutton R,Field JK.Multiple target sites of allelic imbalance on chromosome 17 in Barrett's oesophageal cancer..Oncogene1999;18:987-93

[47] Skacel M,Rybicki LA,Richter JE,Goldblum JR.p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression..Am J Gastroenterol2002;97:2508-13

[48] Chung SM,Hyjek E.p53 in esophageal adenocarcinoma: a critical reassessment of mutation frequency and identification of 72Arg as the dominant allele..Int J Oncol2007;31:1351-5

[49] Mokrowiecka A,Smolarz B,Malecka-Panas E.p16 gene mutations in Barrett's esophagus in gastric metaplasia - intestinal metaplasia - dysplasia - adenocarcinoma sequence..Adv Med Sci2012;57:71-6

[50] Hong J,Behar J,Wands J,Souza RF,Cao W.Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S..Am J Physiol Gastrointest Liver Physiol2010;299:G697-706

[51] Wang JS,Montgomery EA,Cosby H,Wang S,Canto MI.DNA promoter hypermethylation of p16 and APC predicts neoplastic progression in Barrett's esophagus..Am J Gastroenterol2009;104:2153-60 PMCID:PMC3090447

[52] Weaver JM,Shannon N,Forshew T,Murtaza M,Lao-Sirieix P,Smith L,Anderson CL,O'Donovan M,May AP,Hardwick R,Oloumi A,Caldas C,Edwards PA,Tavare S,Consortium O.Ordering of mutations in preinvasive disease stages of esophageal carcinogenesis..Nat Genet2014;46:837-43 PMCID:PMC4116294

[53] Streppel MM,DelaBastide M,Wang JS,Macgregor-Das AM,Morsink FH,Antoniou E,McCombie WR.Next-generation sequencing of endoscopic biopsies identifies ARID1A as a tumor-suppressor gene in Barrett's esophagus..Oncogene2014;33:347-57 PMCID:PMC3805724

[54] Zang ZJ,Poon SL,McPherson JR,Rajasegaran V,Deng N,Lim KH,Huang D,Tan IB,Yu W,Lee M,Poh D,Rha SY,Salto-Tellez M,Wong WK,Futreal PA,Ruan Y,Bertrand D,Rozen S,Tan P.Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes..Nat Genet2012;44:570-4

[55] Wiegand KC,Kalloger SE,Woods R,Streutker CJ,Zhou C,Huntsman DG,Schaeffer DF.ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts..Hum Pathol2014;45:1258-68

[56] Dulak AM,Peng S,Fox C,Bandla S,Schumacher SE,McKenna A,Cibulskis K,Saksena G,Ramos AH,Thompson K,Onofrio RC,Beroukhim R,Lin L,Reddy R,Landrenau R,Ogino S,Golub TR,Lander ES,Godfrey TE,Bass AJ.Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity..Nat Genet2013;45:478-86 PMCID:PMC3678719

[57] Jarzynka MJ,Hui KM,Gu W,Haney LB,Nishikawa R.ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion..Cancer Res2007;67:7203-11 PMCID:PMC2867339

[58] Nones K,Wayte N,Bailey P,Holmes O,Quinn MC,Lampe G,Loffler KA,Idrisoglu S,Xu Q,Wilson PJ,Christ AN,Nourse C,Anderson M,Leonard C,Simpson PT,Krause L,Watson DI,Nancarrow D,Gotley D,Whiteman DC,Campbell PJ,Grimmond SM.Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis..Nat Commun2014;5:5224 PMCID:PMC4596003

[59] Dvorak K,Chavarria M,Dvorakova B,Holubec H,Guy N,Bernstein C,Prasad A.Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett's oesophagus..Gut2007;56:763-71 PMCID:PMC1954874

[60] Satou K,Kawai K,Harashima H.Involvement of specialized DNA polymerases in mutagenesis by 8-hydroxy-dGTP in human cells..DNA Repair (Amst).2009;8:637-42

[61] Xu E,Hawk ET,Lai M,Ajani J.Genome-wide methylation analysis shows similar patterns in Barrett's esophagus and esophageal adenocarcinoma..Carcinogenesis2013;34:2750-6 PMCID:PMC3845893

[62] Alvarez H,Zhou L,Fazzari MJ,Montagna C,Canto M,Wang J,Mo Y,Ramesh KH,Mollenhauer J,Suzuki M,Melnick A,Maitra A.Widespread hypomethylation occurs early and synergizes with gene amplification during esophageal carcinogenesis..PLoS Genet2011;7:e1001356

[63] Alvi MA,O'Donovan M,Wernisch L,Shariff K,Bergman JJ,Fitzgerald RC.DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus..Clin Cancer Res2013;19:878-88 PMCID:PMC4998953

[64] Kaz AM,Stachler MD.Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma..Gastroenterol Clin North Am2015;44:473-89 PMCID:PMC4449457

[65] Eads CA,Kurumboor SK,Skinner ML,Peters JH,Danenberg KD,Laird PW.Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma..Cancer Res2000;60:5021-6

[66] Wong DJ,Prevo LJ,Longton G,Reid BJ.p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium..Cancer Res2001;61:8284-9

[67] Brock MV,Akiyama Y,Wu TT,Deasel M,Rubinson L,Yang SC,Baylin SB.Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma..Clin Cancer Res2003;9:2912-9

[68] Sarbia M,Klump B,Iskender E.Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract..Int J Cancer2004;111:224-8

[69] Smith CM,Michael MZ.MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma..World J Gastroenterol2010;16:531-7 PMCID:PMC2816263

[70] Wijnhoven BP,Watson DI,Smith CM,South Australian Oesophageal Research G.MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma..Br J Surg2010;97:853-61

[71] Mees ST,Wendel C,Willscher E,Schleicher C,Haier J.EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas..Int J Cancer2010;126:114-24

[72] Suzuki HI,Sugimoto K,Kato S.Modulation of microRNA processing by p53..Nature2009;460:529-33

[73] Chen X,Zhang H,Chen J,Cai X,Wang G,Zhu L,Yang R,Ren Z,Zhang J.Role of miR-143 targeting KRAS in colorectal tumorigenesis..Oncogene2009;28:1385-92

[74] Leidner RS,Leahy P,Bednarchik B,Canto M,Maitra A,Markowitz SD,Adams MD,Guda K.The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis..Genes Chromosomes Cancer2012;51:473-9 PMCID:PMC3547654